Broad Institute

MAY 30, 2024

Introduction to Pharmacogenetics By Rose Circeo May 30, 2024 Breadcrumb Home Introduction to Pharmacogenetics The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Pharmacogenetics 52

Pharmacogenetics Bioethics Disease Research 52

The Open Targets Blog

MARCH 20, 2024

  We have implemented this analysis for eight sources of target-disease association evidence where there is enough information available to make an assessment. The assessment is tailored to each dataset; this is detailed in our target-disease evidence documentation. million evidence. is included as independent evidence.

Pharmacogenetics 85

Pharmacogenetics Disease Drugs Research 85

The Open Targets Blog

NOVEMBER 30, 2023

The new page can be accessed from the target-disease associations page when searching for targets associated with a disease, and clicking on the target prioritisation factors tab. Target prioritisation view for Crohn's Disease. Clicking on one of the cells will bring up the data informing the assessment.

Pharmacogenetics 59

Pharmacogenetics Small Molecule Disease Drugs 59

Drug Discovery World

OCTOBER 5, 2022

The company envisions that its bioprinting technologies will help replicate complex disease models with subjects’ own cell lines to be cultured and tested for individual treatment which it states are not currently possible with conventional bioprinting and organ-on-a-chip technologies. .

Pharmacogenetics 130

Pharmacogenetics Regulations Drugs Therapies 130

The Open Targets Blog

MAY 9, 2024

In December 2023, we introduced the pharmacogenetics widget in the Open Targets Platform, which brings in data from PharmGKB on the influence of genetic variation on drug responses. Pharmacogenetics examines the link between genetics and drug response, helping in the prioritisation of drug targets that minimise the risk of adverse effects.

Pharmacogenetics 72

Pharmacogenetics Drugs Therapies Disease 72

Drug Discovery World

OCTOBER 25, 2023

We can use NGS to better understand so-called “pharmacogenetics” so that we can predict how an individual may respond to a given treatment. RA: Are there any disease areas NGS technologies are having a particular impact in? However, NGS will have impact in any genetic-based diseases. DG : For sure!

Bioinformatics 287

Bioinformatics Pharmacogenetics RNA Medical Schools 287

The Pharma Data

OCTOBER 27, 2020

The system is a highly sensitive, cost-effective, mass spectrometry-based platform for high-throughput genetic analysis and is used globally in diverse research fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research.

Pharmacogenetics 52

Pharmacogenetics Laboratories Clinical Research FDA 52